论文部分内容阅读
AIM To determine factors independently influencing response to ingenol mebutate therapy and assess efficacy on clinical setting of non-hypertrophic non-hyperkeratotic actinic keratosis(AK).METHODS Consecutive patients affected by non-hypertrophic nonhyper